An international team of scientists from the Menzies
Health Institute Queensland (MHIQ) at Griffith University and from
City of Hope, a research and treatment center for cancer, diabetes
and other life-threatening diseases in the US, has developed an
experimental direct-acting antiviral therapy to treat
COVID-19.